Long-Term Debt: Immatics Corp (IMTX)

Brandmark of Immatics Biotechnologies (IMTX)

Immatics N.V. (IMTX) brings together top immunology specialists, providing them with innovative tools for developing anti-cancer agents. High barriers to entry in the industry are ensured by costly R&D and the patent protection of AI algorithms. This price chart on GURU.Markets shows debt at 0.01, while the company adheres to environmental regulations and ethical standards in biopharmaceuticals.

IMTX (Immatics Corp) Company Long-Term Debt history from 07/04/2022 to 10/29/2026

Immatics Corp - analytical breakdowns and key metrics (IMTX)

- current quotes and average value forecast:
Stock Quotes immatics.com|IMTX - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Immatics|IMTX - Total Company Value
- book capitalization data:
Net Assets per Single Share Immatics|IMTX - Company Book Value|Market-to-Book Ratio immatics.com|IMTX - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Ratio Immatics N.V.|IMTX - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Immatics Biotechnologies|IMTX - Company Total Debt|Debt to Net Assets Ratio Immatics|IMTX - Company Long-Term Debts|Short-Term Debt Volume Immatics|Quick Liquidity Indicator immatics.com
- net income and valuation multiples indicators:
IMTX - Company Net Income
Fundamental company valuation:immatics.com
Core merchandise of Immatics

To find fundamental support in Immatics N.V. (IMTX), it is critical to align the development pace of the T-cell therapy ecosystem and R&D expenditures with long-term liabilities. By analyzing the firm's long-term debt structure, an investor assesses the aggregate of loans and bonds with maturities exceeding one year, which determines the company's degree of dependence on external financing under strict FDA oversight.

Who Immatics N.V. competes with

IBRX - Company Long-Term Liabilities|IMCR - Company Long-Term Debt|Long-Term Debt Janux Therapeutics Inc|Arcus Bio (RCUS) - Company Long-Term Debt|ZYME (Zymeworks Biopharmaceuticals) - Company Long-Term Debt|Company Long-Term Debt Tango Therapeutics|Long-Term Debt iovance.com IOVA|Company Long-Term Debts XNCR|Compass Therapeutics Inc (CMPX) - Long-Term Indebtedness|Replimune Corp - Company Long-Term Liabilities|Lyell Pharma (LYEL) - Long-Term Debt|IPHA: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings PYXS (Pyxis Oncology, Inc.)|CGEN: Company Long-Term Debts|IOBT - Long-Term Debt Volume|Company Long-Term Debt Sutro Bio|Company Long-Term Liabilities MiNK Therapeutics, Inc (INKT)|Company Long-Term Debt Werewolf Therapeutics (HOWL)|Company Long-Term Liabilities immixbio.com IMMX|ALX Oncology Holdings - Company Long-Term Liabilities|Company Long-Term Debts cuebiopharma.com CUE|PDSB - Company Long-Term Debt|SONN (Sonnet BioTherapeutics) - Company Long-Term Indebtedness|MAIA Biotechnology (MAIA) - Company Long-Term Debt|Long-Term Debt liminatuspharma.com (LIMN)|Company Long-Term Liabilities LVTX|NXTC - Long-Term Indebtedness|Company Long-Term Liabilities LPTX (Leap Therapeutics, Inc.)|Amount of Long-Term Liabilities INTS|Company Long-Term Debts SNSE (Sensei Biotherapeutics, Inc.)|Company Long-Term Loans and Borrowings TOVX|Gritstone Bio - Company Long-Term Debts|Long-Term Debt Kineta Inc|NexImmune Corp (NEXI) - Company Long-Term Debt|Turnstone Biologics Corp. - Company Long-Term Loans and Borrowings|VCNX (Vaccinex, Inc.) - Company Long-Term Debts|Company Long-Term Debts harpoontx.com